| Product Code: ETC9968685 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Joint Disorders Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Joint Disorders Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Joint Disorders Market - Industry Life Cycle |
3.4 United States (US) Joint Disorders Market - Porter's Five Forces |
3.5 United States (US) Joint Disorders Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Joint Disorders Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 United States (US) Joint Disorders Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 United States (US) Joint Disorders Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United States (US) Joint Disorders Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 United States (US) Joint Disorders Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Joint Disorders Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in the US leading to a higher prevalence of joint disorders. |
4.2.2 Rising awareness about the importance of early diagnosis and treatment of joint disorders. |
4.2.3 Technological advancements in orthopedic treatments and surgeries improving patient outcomes. |
4.3 Market Restraints |
4.3.1 High costs associated with joint disorder treatments and surgeries. |
4.3.2 Limited insurance coverage for certain advanced treatments and therapies. |
4.3.3 Regulatory challenges and stringent approval processes for new orthopedic products. |
5 United States (US) Joint Disorders Market Trends |
6 United States (US) Joint Disorders Market, By Types |
6.1 United States (US) Joint Disorders Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Joint Disorders Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Joint Disorders Market Revenues & Volume, By Osteoarthritis, 2021- 2031F |
6.1.4 United States (US) Joint Disorders Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.1.5 United States (US) Joint Disorders Market Revenues & Volume, By Spondylarthritis, 2021- 2031F |
6.1.6 United States (US) Joint Disorders Market Revenues & Volume, By Juvenile Idiopathic Arthritis, 2021- 2031F |
6.1.7 United States (US) Joint Disorders Market Revenues & Volume, By Lupus, 2021- 2031F |
6.1.8 United States (US) Joint Disorders Market Revenues & Volume, By Gout, 2021- 2031F |
6.1.9 United States (US) Joint Disorders Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 United States (US) Joint Disorders Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Joint Disorders Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Joint Disorders Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.2.3 United States (US) Joint Disorders Market Revenues & Volume, By X-ray, 2021- 2031F |
6.2.4 United States (US) Joint Disorders Market Revenues & Volume, By MRI, 2021- 2031F |
6.2.5 United States (US) Joint Disorders Market Revenues & Volume, By Ultrasound, 2021- 2031F |
6.2.6 United States (US) Joint Disorders Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.2.7 United States (US) Joint Disorders Market Revenues & Volume, By DEXA Scan, 2021- 2031F |
6.3 United States (US) Joint Disorders Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Joint Disorders Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 United States (US) Joint Disorders Market Revenues & Volume, By Therapy, 2021- 2031F |
6.3.4 United States (US) Joint Disorders Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3.5 United States (US) Joint Disorders Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Joint Disorders Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Joint Disorders Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United States (US) Joint Disorders Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 United States (US) Joint Disorders Market Revenues & Volume, By Topical, 2021- 2031F |
6.4.5 United States (US) Joint Disorders Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Joint Disorders Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Joint Disorders Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United States (US) Joint Disorders Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 United States (US) Joint Disorders Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Joint Disorders Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Joint Disorders Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United States (US) Joint Disorders Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 United States (US) Joint Disorders Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Joint Disorders Market Import-Export Trade Statistics |
7.1 United States (US) Joint Disorders Market Export to Major Countries |
7.2 United States (US) Joint Disorders Market Imports from Major Countries |
8 United States (US) Joint Disorders Market Key Performance Indicators |
8.1 Average waiting time for joint disorder treatment services. |
8.2 Patient satisfaction rates with orthopedic care facilities. |
8.3 Number of orthopedic research and development collaborations fostering innovation in joint disorder treatments. |
9 United States (US) Joint Disorders Market - Opportunity Assessment |
9.1 United States (US) Joint Disorders Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Joint Disorders Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 United States (US) Joint Disorders Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 United States (US) Joint Disorders Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United States (US) Joint Disorders Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 United States (US) Joint Disorders Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Joint Disorders Market - Competitive Landscape |
10.1 United States (US) Joint Disorders Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Joint Disorders Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here